Thomas Berryman
Chief Financial Officer @ Q'Apel Medical
Tom Berryman Chief Financial Officer
Tom Berryman is the Chief Financial Officer known for his significant contributions to various medical technology companies. He founded Privy, which developed Finess, a novel FDA-cleared technology aimed at a large consumer health market. With extensive experience in senior leadership roles, Berryman has established himself as an influential figure in the medical technology sector.
Founder of Privy and Developer of Finess
Tom Berryman founded Privy, the creator of Finess, a novel technology that has received FDA clearance and clinical validation. Finess is designed to address a large consumer health market, demonstrating Berryman's capability to innovate and deliver impactful health solutions.
President and CEO of WaveTec Vision Systems
From its initial venture funding in 2005 until September 2010, Tom Berryman served as President and CEO of WaveTec Vision Systems. During his tenure, he guided the company from a benchtop prototype through clinical validation and early commercialization, showcasing his leadership in advancing medical technologies.
Founder/CEO of Genyx Medical, Inc.
Tom Berryman founded and served as CEO of Genyx Medical, Inc., a medical technology company. He successfully led the company until its acquisition by C.R. Bard in 2005, highlighting his ability to drive business growth and achieve successful exits.
Former CFO at Micro Therapeutics, Inc.
Between 1994 and 1997, Tom Berryman held the position of CFO at Micro Therapeutics, Inc., now known as Medtronic Neurovascular. His role as CFO during this period is a testament to his financial acumen and his role in steering the company through significant phases of its development.